Yoga Asana sessions increase brain GABA levels: A pilot study

Journal of Alternative and Complementary Medicine

Volumn 13, Issue 4, 2007, Pages 419-426

  Streeter, Chris C ^a,b,c   Jensen, J Eric ^b,c   Perlmutter, Ruth M ^a   Cabral, Howard J ^d   Tian, Hua ^a   Terhune, Devin B ^a   Ciraulo, Domenic A ^a,c,e   Renshaw, Perry F ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY   (United States)

^e Boston VA Healthcare System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CREATINE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; ANXIETY DISORDER; ARTICLE; COMPARATIVE STUDY; DEPRESSION; EXERCISE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; READING; TREATMENT INDICATION; YOGA;

ADULT; AFFECT; ANXIETY; BRAIN; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEDITATION; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; STRESS, PSYCHOLOGICAL; YOGA;

EID: 34249003919     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2007.6338     Document Type: Article

References (39)

1. Iyengar BKS. Light on Yoga. New York: Schocken Books, 1966.
2. Lowitz L, Datta R. Sacred Sanskrit Words, for Yoga Chant and Meditation. Berkeley, CA: Stone Bridge Press, 2005.
3. Barnes PM, Powell-Griner E, McFann K, et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;343:1-19.
4. Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, et al. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: A randomized comparison with electroconvulsive therapy (ECT) and imipramine. J Affect Disord 2000;57:255-259.
5. Girodo M. Yoga meditation and flooding in the treatment of anxiety neurosis. J Behav Ther Exp Psychiatry 1974;5:157-160.
6. Shannahoff-Khalsa D, Ray D, Levine S, et al. Randomized controlled trial of yogic meditation techniques for patients with obsessive compulsive disorders. CNS Spectrums 1999;4:34-46.
7. Yardi N. Yoga for the control of epilepsy. Seizure 2001;10:7-12.
8. Ramaratnam S, Sridharan K. Yoga for epilepsy. Cochrane Database Syst Rev 2000;3:CD001524.
9. Panjwani U, Selvamurthy W, Singh S, et al. Effect of Sahaja yoga meditation on seizure control and EEG changes in patients of epilepsy. Indian J Med Res 1996;103:165-172.
10. Khalsa S. Yoga as a therapeutic intervention: A bibliometric analysis of published research studies. Indian J Physiol Pharmacol 2004;48:269-285.
11. Sanacora G, Mason GF, Rothman DL, et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999;56:1043-1047.
12. Petroff O, Rothman D, Behar K, et al. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996;47:1567-1571.
13. Sendrowski K, Sobaniec W. New antiepileptic drugs - an overview. Rocz Akad Med Bialymst 2005;50(suppl 1):96-98.
14. Keck JP, McElroy S. Antiepileptic Drugs. Washington, DC: American Psychiatric Press, 1998.
15. Brambilla P, Perez J, Barale F, et al. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003;8:721-737.
16. Schatzberg AF, Nemeroff C. Textbook of Psychopharmacology. Washington, D.C.: American Psychiatric Press, 1998.
17. Taylor C. Treatment of Anxiety Disorders. Washington, DC: American Psychiatric Press, 1998.
18. Breier A, Paul S. The GABAa/benzodiazepine receptor: Implications for the molecular basis of anxiety. J Psychiatr Res 1990;24:91-104.
19. Kasa K, Otsuki S, Yamamoto M, et al. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. Biol Psychiatry 1982;17:877-883.
20. Sanacora G, Mason GF, Rothman DL, et al. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002;159(4):663-665.
21. Sanacora G, Mason GF, Rothman DL, et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003;160:577-579.
22. Goddard AW, Mason GF, Almai A, et al. Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 2001;58:556-561.
23. Lydiard RB. The role of GABA in anxiety disorders. J Clin Psychiatry 2003;64(suppl 3):21-27.
24. Goddard A, Mason G, Appel M, et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 2004;161:2186-2193.
25. Kirkwood G, Rampes H, Tuffrey V, et al. Yoga for anxiety: A systematic review of the research evidence. Br J Sports Med 2005;39:884-891.
26. Pilkington K, Kirkwood G, Rampes H, et al. Yoga for depression: The research evidence. J Affect Disord 2005;89:13-24.
27. Meldrum S. GABAergic mechanisms in the pathogenesis and treatment of epilepsy. Br J Clin Pharmacol 1989;27:3S-11S.
28. Petroff OA, Hyder F, Rothman DL, et al. Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 2001;42:543-548.
29. First MB, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders: Patient Edition (SCID-I/P, Version 2.0). New York: Biometric Research Department, New York State University, 1995.
30. McLellan A, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:119-213.
31. Griffiths J, Lovick T. Withdrawal from progesterone increases expression of alpha4, beta1 and delta GABA(A) receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats. J Comp Neurol 2005;486:89-97.
32. Epperson CN, Haga K, Mason GF, et al. Cortical gammaaminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2002;59:851-858.
33. Jensen J, Frederick B, Brown J, et al. Two-dimensional, J-resolved spectroscopic imaging of GABA at 4 Tesla in the human brain. Magnetic Resonance in Medicine 2005;54:783-788.
34. Jensen J, Frederick B, Renshaw P. Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging. NMR Biomed 2005;18:570-576.
35. Dager SR, Friedman SD, Parow A, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004;61:450-458.
36. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
37. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260-264.
38. Murray C, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press, 1996.
39. Barbee JG. Mixed symptoms and syndromes of anxiety and depression: Diagnostic, prognostic, and etiologic issues. Ann Clin Psychiatry 1998;10:15-29.